Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2010
Outpatient parenteral antimicrobial therapy todayJoseph A Paladino, Donald PoretzAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 31, 2002
Linezolid: an oxazolidinone antimicrobial agentJoseph A PaladinoPharmacoeconomics|June 17, 2010
Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision modelJack Brown, Joseph A PaladinoThe Journal of Antimicrobial Chemotherapy|April 19, 2003
Fluoroquinolone benchmarking in relation to pharmacokinetic and pharmacodynamic parametersJoseph A Paladino, Wendy A CallenPharmacoeconomics|July 11, 2013
Protease inhibitors for hepatitis C: economic implicationsStuart J Turner, Jack Brown, Joseph A PaladinoInternational Journal of Antimicrobial Agents|March 4, 2008
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infectionsPeggy S McKinnon, Joseph A Paladino, Jerome J SchentagPharmacoeconomics|May 9, 2014
A review of the economics of treating Clostridium difficile infectionKari A Mergenhagen, Amy L Wojciechowski, Joseph A PaladinoPharmacoeconomics|February 6, 2010
Cost effectiveness of respiratory syncytial virus prophylaxis: a critical and systematic reviewWilliam A Prescott, Fred Doloresco, Jack Brown, et al.The Journal of Antimicrobial Chemotherapy|July 31, 2003
Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosaJoseph A Paladino, Jenna L Sunderlin, Alan Forrest, et al.Pageof 3